{"id":"W2004018927","doi":"10.1016/j.lungcan.2011.12.003","title":"Erlotinib or best supportive care for third-line treatment of advanced non-small-cell lung cancer: A real-world cost-effectiveness analysis","year":2012,"lang":"en","type":"article","venue":"Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Ministry of Health; Canadian Centre for Applied Research in Cancer Control","funders":"BC Cancer Agency","keywords":"Erlotinib; Medicine; Lung cancer; Internal medicine; Oncology; Cost-effectiveness analysis; Cohort; Survival analysis; Erlotinib Hydrochloride; Cost effectiveness; Univariate analysis; Population; Cancer; Multivariate analysis; Epidermal growth factor receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00009752737,0.0004167033,0.001104435,0.0003281207,0.0001654579,0.00001442369,0.00009406031,0.0001103785,0.0003276368],"category_scores_gemma":[0.00001510333,0.0002983067,0.0004806847,0.001005251,0.00006208136,0.000156567,0.00002466876,0.00008858534,0.0000027803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002960635,"about_ca_system_score_gemma":0.001059084,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01309129,"about_ca_topic_score_gemma":0.02006359,"domain_scores_codex":[0.9980433,0.00005498468,0.0004860825,0.0005171004,0.000256737,0.0006417683],"domain_scores_gemma":[0.9980386,0.0002571099,0.0003687673,0.0004744804,0.0005403764,0.0003207056],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003484445,0.001904944,0.9306322,0.002766042,0.01060417,0.00002121305,0.01415748,0.004775846,0.001912612,0.0000536911,0.000516811,0.02917059],"study_design_scores_gemma":[0.05393888,0.006115966,0.5570798,0.002781933,0.1563895,0.000009216252,0.00909798,0.006453075,0.1698432,0.000009768819,0.03651047,0.00177013],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9539902,0.02464046,0.001484796,0.0002561742,0.001047503,0.01060705,0.002856801,0.0000985001,0.005018542],"genre_scores_gemma":[0.9699473,0.00367857,0.00126634,0.00009735775,0.0005033175,0.01175647,0.0006988927,0.000080519,0.01197122],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3735524,"threshold_uncertainty_score":0.9999469,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0286214190087518,"score_gpt":0.4102303832821982,"score_spread":0.3816089642734464,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}